Enzon Pharmaceuticals's total assets for Q3 2025 were $43.69M, a decrease of ― from the previous quarter. ENZN total liabilities were $44.62M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.